Javascript must be enabled to continue!
A novel role for central ACBP/DBI as a regulator of long‐chain fatty acid metabolism in astrocytes
View through CrossRef
AbstractAcyl‐CoA‐binding protein (ACBP) is a ubiquitously expressed protein that binds intracellular acyl‐CoA esters. Several studies have suggested that ACBP acts as an acyl‐CoA pool former and regulates long‐chain fatty acids (LCFA) metabolism in peripheral tissues. In the brain, ACBP is known as Diazepam‐Binding Inhibitor, a secreted peptide acting as an allosteric modulator of the GABAA receptor. However, its role in central LCFA metabolism remains unknown. In the present study, we investigated ACBP cellular expression, ACBP regulation of LCFA intracellular metabolism, FA profile, and FA metabolism‐related gene expression using ACBP‐deficient and control mice. ACBP was mainly found in astrocytes with high expression levels in the mediobasal hypothalamus. We demonstrate that ACBP deficiency alters the central LCFA‐CoA profile and impairs unsaturated (oleate, linolenate) but not saturated (palmitate, stearate) LCFA metabolic fluxes in hypothalamic slices and astrocyte cultures. In addition, lack of ACBP differently affects the expression of genes involved in FA metabolism in cortical versus hypothalamic astrocytes. Finally, ACBP deficiency increases FA content and impairs their release in response to palmitate in hypothalamic astrocytes. Collectively, these findings reveal for the first time that central ACBP acts as a regulator of LCFA intracellular metabolism in astrocytes.
image
Acyl‐CoA‐binding protein (ACBP) or diazepam‐binding inhibitor is a secreted peptide acting centrally as a GABAA allosteric modulator. Using brain slices, cortical, and hypothalamic astrocyte cultures from ACBP KO mice, we demonstrate that ACBP mainly localizes in astrocytes and regulates unsaturated but not saturated long‐chain fatty acids (LCFA) metabolism. In addition, ACBP deficiency alters FA metabolism‐related genes and results in intracellular FA accumulation while affecting their release. Our results support a novel role for ACBP in brain lipid metabolism. FA, fatty acids; KO, knockout; PL, phospholipids; TAG, triacylglycerol.
Title: A novel role for central ACBP/DBI as a regulator of long‐chain fatty acid metabolism in astrocytes
Description:
AbstractAcyl‐CoA‐binding protein (ACBP) is a ubiquitously expressed protein that binds intracellular acyl‐CoA esters.
Several studies have suggested that ACBP acts as an acyl‐CoA pool former and regulates long‐chain fatty acids (LCFA) metabolism in peripheral tissues.
In the brain, ACBP is known as Diazepam‐Binding Inhibitor, a secreted peptide acting as an allosteric modulator of the GABAA receptor.
However, its role in central LCFA metabolism remains unknown.
In the present study, we investigated ACBP cellular expression, ACBP regulation of LCFA intracellular metabolism, FA profile, and FA metabolism‐related gene expression using ACBP‐deficient and control mice.
ACBP was mainly found in astrocytes with high expression levels in the mediobasal hypothalamus.
We demonstrate that ACBP deficiency alters the central LCFA‐CoA profile and impairs unsaturated (oleate, linolenate) but not saturated (palmitate, stearate) LCFA metabolic fluxes in hypothalamic slices and astrocyte cultures.
In addition, lack of ACBP differently affects the expression of genes involved in FA metabolism in cortical versus hypothalamic astrocytes.
Finally, ACBP deficiency increases FA content and impairs their release in response to palmitate in hypothalamic astrocytes.
Collectively, these findings reveal for the first time that central ACBP acts as a regulator of LCFA intracellular metabolism in astrocytes.
image
Acyl‐CoA‐binding protein (ACBP) or diazepam‐binding inhibitor is a secreted peptide acting centrally as a GABAA allosteric modulator.
Using brain slices, cortical, and hypothalamic astrocyte cultures from ACBP KO mice, we demonstrate that ACBP mainly localizes in astrocytes and regulates unsaturated but not saturated long‐chain fatty acids (LCFA) metabolism.
In addition, ACBP deficiency alters FA metabolism‐related genes and results in intracellular FA accumulation while affecting their release.
Our results support a novel role for ACBP in brain lipid metabolism.
FA, fatty acids; KO, knockout; PL, phospholipids; TAG, triacylglycerol.
Related Results
Role of astroglial
ACBP
in energy metabolism flexibility and feeding responses to metabolic challenges in male mice
Role of astroglial
ACBP
in energy metabolism flexibility and feeding responses to metabolic challenges in male mice
Abstract
Acyl‐CoA binding protein (ACBP), also known as diazepam binding inhibitor (DBI), has recently emerged as a hypothalamic and brainstem gliopeptide regulat...
Role of astroglial ACBP in energy metabolism flexibility and feeding responses to metabolic challenges in male mice
Role of astroglial ACBP in energy metabolism flexibility and feeding responses to metabolic challenges in male mice
ABSTRACT
Acyl-CoA Binding Protein (ACBP), also known as Diazepam Binding Inhibitor (DBI), has recently emerged as a hypothalamic and brainstem gliopeptide regulatin...
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
Astrocytes improve neuronal health after cisplatin treatment through mitochondrial transfer
AbstractNeurodegenerative disorders, including chemotherapy-induced cognitive impairment, are associated with neuronal mitochondrial dysfunction. Cisplatin, a commonly used chemoth...
The adhesion GPCR ADGRV1 controls glutamate homeostasis in hippocampal astrocytes supporting neuron development: first insights into to pathophysiology of
ADGRV1
-associated epilepsy
The adhesion GPCR ADGRV1 controls glutamate homeostasis in hippocampal astrocytes supporting neuron development: first insights into to pathophysiology of
ADGRV1
-associated epilepsy
Abstract
ADGRV1 is the largest member of adhesion G protein-coupled receptor (aGPCR) family. In the cell, aGPCRs have dual roles in cell adhesion...
Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Circulating diazepam‐binding inhibitor in infancy: Relation to markers of adiposity and metabolic health
Circulating diazepam‐binding inhibitor in infancy: Relation to markers of adiposity and metabolic health
SummaryBackgroundDiazepam‐binding inhibitor (DBI) controls feeding behaviour and glucose homeostasis. Individuals born small‐for‐gestational‐age (SGA) with excessive postnatal catc...
Low Temperature Affects Fatty Acids Profiling and Key Synthesis Genes Expression Patterns in Zanthoxylum bungeanum Maxim
Low Temperature Affects Fatty Acids Profiling and Key Synthesis Genes Expression Patterns in Zanthoxylum bungeanum Maxim
Zanthoxylum bungeanum is one of the most important medicinal and edible homologous plants because of its potential health benefits and unique flavors. The chemical components in co...
Fatty Acid Incorporation into Human Adipose Tissue in Hypertrigiyceridaemia*
Fatty Acid Incorporation into Human Adipose Tissue in Hypertrigiyceridaemia*
AbstractThe fatty acid and glucose incorporation into glycerides and glycerol release from adipose tissue were determined in a middle‐aged population of 109 men and 41 women. 43 me...

